ConvaTec Group’s (CTEC) “Add” Rating Reiterated at Peel Hunt

Peel Hunt reiterated their add rating on shares of ConvaTec Group (LON:CTEC) in a report released on Tuesday,Digital Look reports. They currently have a GBX 270 price target on the stock.

CTEC has been the subject of a number of other reports. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 315 price target on shares of ConvaTec Group in a report on Monday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, April 8th. UBS Group reaffirmed a “buy” rating and issued a GBX 375 price objective on shares of ConvaTec Group in a research note on Monday, May 18th. Berenberg Bank reissued a “buy” rating and set a GBX 340 price objective on shares of ConvaTec Group in a report on Tuesday, April 21st. Finally, Jefferies Financial Group reiterated a “buy” rating and set a GBX 300 price target on shares of ConvaTec Group in a report on Monday, June 8th. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, ConvaTec Group presently has a consensus rating of “Moderate Buy” and an average target price of GBX 306.

ConvaTec Group Price Performance

Shares of CTEC opened at GBX 226.80 on Tuesday. The firm has a market cap of £4.43 billion, a PE ratio of 26.37, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. ConvaTec Group has a 52-week low of GBX 193 and a 52-week high of GBX 259.30. The company has a debt-to-equity ratio of 121.83, a quick ratio of 0.96 and a current ratio of 1.93. The business’s 50 day moving average price is GBX 212.78 and its two-hundred day moving average price is GBX 220.93.

Insider Activity at ConvaTec Group

In other ConvaTec Group news, insider Jonny Mason purchased 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was bought at an average cost of GBX 201 per share, with a total value of £100,500. Insiders own 0.98% of the company’s stock.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.